Ruud Houben

4.7k total citations
93 papers, 3.4k citations indexed

About

Ruud Houben is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ruud Houben has authored 93 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 35 papers in Oncology and 24 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ruud Houben's work include Lung Cancer Diagnosis and Treatment (20 papers), Lung Cancer Treatments and Mutations (18 papers) and Advanced Radiotherapy Techniques (15 papers). Ruud Houben is often cited by papers focused on Lung Cancer Diagnosis and Treatment (20 papers), Lung Cancer Treatments and Mutations (18 papers) and Advanced Radiotherapy Techniques (15 papers). Ruud Houben collaborates with scholars based in Netherlands, Belgium and United States. Ruud Houben's co-authors include Philippe Lambin, Johan W.S. Vlaeyen, Dirk De Ruysscher, Anne‐Marie C. Dingemans, Angela van Baardwijk, Liesbeth Boersma, Madelon L. Peters, Rinus Wanders, Pieter Wolters and Raymond Ostelo and has published in prestigious journals such as The Lancet Oncology, Clinical Cancer Research and Cochrane Database of Systematic Reviews.

In The Last Decade

Ruud Houben

88 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruud Houben Netherlands	32	1.3k	972	891	604	541	93	3.4k
May Abdel–Wahab United States	29	875 0.7×	683 0.7×	842 0.9×	206 0.3×	508 0.9×	194	4.1k
Mohamed Abdolell Canada	32	1.1k 0.8×	514 0.5×	671 0.8×	161 0.3×	281 0.5×	108	3.8k
Stephen P. Povoski United States	35	1.0k 0.8×	1.3k 1.4×	683 0.8×	92 0.2×	179 0.3×	142	4.1k
Gerald H. Clamon United States	30	2.6k 2.0×	1.9k 2.0×	554 0.6×	79 0.1×	460 0.9×	115	4.7k
Shawn Malone Canada	31	2.7k 2.1×	1.3k 1.3×	586 0.7×	50 0.1×	610 1.1×	168	4.5k
Peter A.S. Johnstone United States	35	1.4k 1.1×	1.4k 1.5×	489 0.5×	59 0.1×	548 1.0×	173	4.3k
Henry Lam Canada	32	524 0.4×	1.0k 1.1×	437 0.5×	99 0.2×	226 0.4×	112	3.0k
Henry S. Park United States	38	1.6k 1.2×	1.3k 1.3×	653 0.7×	45 0.1×	332 0.6×	170	4.3k
Nigel Spry Australia	51	3.9k 3.0×	4.6k 4.7×	972 1.1×	118 0.2×	950 1.8×	227	9.1k
Chang Geol Lee South Korea	36	1.2k 1.0×	1.5k 1.5×	372 0.4×	51 0.1×	246 0.5×	157	4.0k

Countries citing papers authored by Ruud Houben

Since Specialization

Citations

This map shows the geographic impact of Ruud Houben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruud Houben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruud Houben more than expected).

Fields of papers citing papers by Ruud Houben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruud Houben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruud Houben. The network helps show where Ruud Houben may publish in the future.

Co-authorship network of co-authors of Ruud Houben

This figure shows the co-authorship network connecting the top 25 collaborators of Ruud Houben. A scholar is included among the top collaborators of Ruud Houben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruud Houben. Ruud Houben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palm, Denise, Joost J.C. Verhoeff, Catharina M.L. Zegers, et al.. (2025). 4346 Repeat Chemoradiation vs. Re-Irradiation Alone in Recurrent Gliomas. Radiotherapy and Oncology. 206. S760–S761.

Houben, Ruud, Meltem Demirel Kars, Hanneke M. van Santen, et al.. (2024). Radiotherapy-induced Hypothalamic-Pituitary axis dysfunction in adult Brain, head and neck and skull base tumor patients – A systematic review and Meta-Analysis. Clinical and Translational Radiation Oncology. 51. 100900–100900.

Zeng, Haiyan, Lizza Hendriks, J. Belderbos, et al.. (2024). Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial. Clinical Lung Cancer. 25(7). 653–659.e1. 1 indexed citations

Zeng, Haiyan, Lizza Hendriks, Harry J.M. Groen, et al.. (2023). Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study. Radiotherapy and Oncology. 183. 109627–109627. 5 indexed citations

Popp, Ilinca, Rianne D.W. Vaes, Lotte Wieten, et al.. (2023). Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trials. Radiotherapy and Oncology. 190. 110048–110048. 7 indexed citations

Degens, Juliette, Dirk De Ruysscher, Ruud Houben, et al.. (2020). Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study. BMJ Open. 10(9). e036492–e036492. 5 indexed citations

Guillem, José G., Rodrigo Oliva Perez, Krzysztof Bujko, et al.. (2019). Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data. Radiotherapy and Oncology. 144. 37–45. 4 indexed citations

Ruysscher, Dirk De, Rinus Wanders, Lizza Hendriks, et al.. (2018). Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450). Journal of Thoracic Oncology. 13(12). 1958–1961. 63 indexed citations

Poort, Lucas J., et al.. (2016). Osseointegration and implant stability of extraoral implants in Göttingen minipigs after irradiation. Journal of Cranio-Maxillofacial Surgery. 44(11). 1842–1848. 1 indexed citations

10.

Sanders, Karin J.C., Lizza Hendriks, Esther G.C. Troost, et al.. (2016). Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC. Journal of Thoracic Oncology. 11(6). 873–879. 39 indexed citations

11.

Lussanet, Quido G. de, Ruud Houben, Dirk De Ruysscher, et al.. (2015). Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib. Lung Cancer. 93. 20–27. 2 indexed citations

12.

Oberije, Cary, Dirk De Ruysscher, Ruud Houben, et al.. (2015). A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients. International Journal of Radiation Oncology*Biology*Physics. 92(4). 935–944. 76 indexed citations

13.

Hendriks, Lizza, Jules L. Derks, Pieter E. Postmus, et al.. (2015). Single Organ Metastatic Disease, a New Prognostic Factor for Overall Survival (OS) in Stage IV Non-Small Cell Lung Cancer (NSCLC). Annals of Oncology. 26. i29–i29. 1 indexed citations

14.

Zegers, Catharina M.L., Wouter van Elmpt, Bart Reymen, et al.. (2014). In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging. Clinical Cancer Research. 20(24). 6389–6397. 69 indexed citations

15.

Hendriks, Lizza, Egbert F. Smit, Bettine A.H. Vosse, et al.. (2014). EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?. Lung Cancer. 84(1). 86–91. 95 indexed citations

16.

Boersma, Liesbeth, C. Boetes, Jacques Borger, et al.. (2011). Is contrast enhancement required to visualize a known breast tumor in a pre-operative CT scan?. Radiotherapy and Oncology. 100(2). 271–275. 3 indexed citations

17.

Borger, Jacques, et al.. (2008). Evaluation of three different CT simulation and planning procedures for the preoperative irradiation of operable rectal cancer. Radiotherapy and Oncology. 87(3). 350–356. 7 indexed citations

18.

Loon, Judith van, Geert Bosmans, Rinus Wanders, et al.. (2008). 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: A planning study. Radiotherapy and Oncology. 87(1). 49–54. 59 indexed citations

19.

Ruysscher, Dirk De, Johan Bussink, Patrick Rodrigus, et al.. (2007). Concurrent celecoxib versus placebo in patients with stage II–III non-small cell lung cancer: A randomised phase II trial. Radiotherapy and Oncology. 84(1). 23–25. 11 indexed citations

20.

Baardwijk, Angela van, Geert Bosmans, André Dekker, et al.. (2007). Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients. Radiotherapy and Oncology. 82(2). 145–152. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact